$15.21
0.372.46%
Ultimo aggiornamento: 11:54 AM
Comments
Loading...
Phathom Pharmaceuticals Rapporto sugli interessi allo scoperto
PHATNASDAQ
Report sulle vendite allo scoperto
Il short interest su Phathom Pharmaceuticals Inc (NASDAQ:PHAT) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 14.13M a 13.57M. Questo rappresenta il 31.43% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 998.57K azioni scambiate al giorno, ci vorrebbero 13.59 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
13.57M
Vendite allo scoperto %
31.4%
Giorni di copertura
13.59
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
PHAT | Phathom Pharmaceuticals, Inc. | 10/31/2025 | 11/11/2025 | 31.43% | 43,161,906 | 13,566,849 | 998,568 | 13.59 | |
PHAT | Phathom Pharmaceuticals, Inc. | 10/15/2025 | 10/24/2025 | 32.88% | 42,967,174 | 14,125,695 | 1,524,284 | 9.27 | |
PHAT | Phathom Pharmaceuticals, Inc. | 09/30/2025 | 10/09/2025 | 30.72% | 42,967,174 | 13,199,013 | 1,232,883 | 10.71 | |
PHAT | Phathom Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 32.58% | 42,967,174 | 13,999,721 | 1,156,172 | 12.11 | |
PHAT | Phathom Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 30.66% | 42,967,174 | 13,172,777 | 1,024,288 | 12.86 | |
PHAT | Phathom Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | 28.15% | 42,967,174 | 12,093,175 | 1,140,164 | 10.61 | |
PHAT | Phathom Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 23.49% | 42,967,174 | 10,092,540 | 1,027,206 | 9.83 | |
PHAT | Phathom Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 23.25% | 41,671,753 | 9,689,813 | 950,131 | 10.2 | |
PHAT | Phathom Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 20.45% | 41,671,753 | 8,520,349 | 1,739,128 | 4.9 | |
PHAT | Phathom Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 26.49% | 41,671,753 | 11,038,334 | 8,037,035 | 1.37 | |
PHAT | Phathom Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 26.35% | 41,671,753 | 10,981,222 | 1,101,413 | 9.97 | |
PHAT | Phathom Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 26.82% | 41,671,753 | 11,177,554 | 3,514,554 | 3.18 | |
PHAT | Phathom Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 26.20% | 41,671,753 | 10,918,242 | 1,002,960 | 10.89 | |
PHAT | Phathom Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 27.32% | 41,671,753 | 11,384,551 | 1,360,525 | 8.37 | |
PHAT | Phathom Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 25.97% | 49,709,640 | 12,910,348 | 1,283,194 | 10.06 | |
PHAT | Phathom Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 28.88% | 49,709,640 | 14,355,935 | 1,452,389 | 9.88 | |
PHAT | Phathom Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 28.01% | 49,709,640 | 13,923,473 | 922,591 | 15.09 | |
PHAT | Phathom Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 30.67% | 48,450,049 | 14,861,562 | 1,019,170 | 14.58 | |
PHAT | Phathom Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 30.20% | 48,450,049 | 14,630,807 | 1,091,108 | 13.41 | |
PHAT | Phathom Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 29.32% | 48,450,049 | 14,203,975 | 873,215 | 16.27 | |
PHAT | Phathom Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 30.87% | 48,450,049 | 14,954,493 | 1,036,329 | 14.43 | |
PHAT | Phathom Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 29.17% | 48,450,049 | 14,131,833 | 953,299 | 14.82 | |
PHAT | Phathom Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 29.01% | 48,450,049 | 14,054,465 | 1,112,687 | 12.63 | |
PHAT | Phathom Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 30.27% | 48,450,049 | 14,663,729 | 2,558,275 | 5.73 | |
PHAT | Phathom Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 36.02% | 48,450,049 | 17,450,062 | 958,504 | 18.21 | |
PHAT | Phathom Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 45.89% | 38,253,013 | 17,555,904 | 995,016 | 17.64 | |
PHAT | Phathom Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 45.02% | 38,253,013 | 17,219,985 | 1,217,672 | 14.14 | |
PHAT | Phathom Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 40.57% | 38,253,013 | 15,517,989 | 990,079 | 15.67 | |
PHAT | Phathom Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 40.09% | 38,253,013 | 15,337,540 | 990,012 | 15.49 | |
PHAT | Phathom Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 46.47% | 29,557,361 | 13,734,601 | 940,614 | 14.6 | |
PHAT | Phathom Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 45.90% | 28,498,583 | 13,080,324 | 666,248 | 19.63 | |
PHAT | Phathom Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 47.04% | 28,498,583 | 13,404,482 | 651,950 | 20.56 | |
PHAT | Phathom Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 45.97% | 28,498,583 | 13,102,071 | 408,199 | 32.1 | |
PHAT | Phathom Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 43.26% | 28,498,583 | 12,329,220 | 471,415 | 26.15 | |
PHAT | Phathom Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 42.74% | 28,498,583 | 12,180,104 | 665,519 | 18.3 | |
PHAT | Phathom Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 41.39% | 28,498,583 | 11,795,035 | 475,262 | 24.82 | |
PHAT | Phathom Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 42.24% | 28,487,491 | 12,032,035 | 933,418 | 12.89 | |
PHAT | Phathom Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 26.13% | 40,750,064 | 10,647,009 | 828,200 | 12.86 | |
PHAT | Phathom Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 25.63% | 40,750,064 | 10,444,308 | 783,715 | 13.33 | |
PHAT | Phathom Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 21.28% | 40,750,064 | 8,671,660 | 1,661,698 | 5.22 | |
PHAT | Phathom Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 23.41% | 39,525,232 | 9,253,085 | 719,564 | 12.86 | |
PHAT | Phathom Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 21.83% | 39,525,232 | 8,627,221 | 631,511 | 13.66 | |
PHAT | Phathom Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 20.73% | 39,525,232 | 8,193,075 | 535,116 | 15.31 | |
PHAT | Phathom Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 17.90% | 39,525,232 | 7,076,483 | 351,040 | 20.16 | |
PHAT | Phathom Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 15.86% | 39,525,232 | 6,267,827 | 653,468 | 9.59 | |
PHAT | Phathom Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 13.92% | 39,525,232 | 5,502,580 | 446,932 | 12.31 | |
PHAT | Phathom Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 12.31% | 39,525,232 | 4,865,000 | 797,158 | 6.1 |
In cerca di azioni più vendute allo scoperto?